Andersen Global Expands in Bosnia and Herzegovina
Andersen Global announces it has entered into a collaboration agreement with a full-service law firm in Bosnia and Herzegovina. Banja Luka-based SAJIĆ is the fourth firm in the region to sign a Collaboration Agreement with Andersen Global in the last month.
Owner and Managing Partner Aleksandar Sajic founded the firm in 2003 and has expanded it to include four partners and nearly 20 professionals. SAJIĆ provides an array of legal services to clients including civil litigation, family law, corporate negotiations, intellectual property, science and technology, and tax. This collaboration expands Andersen Global’s coverage to include nearly 65 countries around the world with legal services in over 55 countries.
“Collaborating with Andersen Global enhances our service offerings and extends our cross-border reach,” said Aleksandar. “The organization’s global platform allows us to expand our capabilities and bring the benefits of a global firm to our clients.”
“The addition of SAJIĆ provides us with a formidable solution in the region that will enable our firm to compete with the top firms in the region,” said Mark Vorsatz, Andersen Global Chairman and Andersen CEO. “Aleksandar and his team already have solid working relationships with our other legal firms in the region: Miro Senica and Attorneys in Slovenia, Kallay & Partners in Croatia and JSP in Serbia, and we will continue to add quality groups that embrace our values and bolster our ability to provide seamless, best-in-class client solutions worldwide.”
Andersen Global is an international association of legally separate, independent member firms comprised of tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has nearly 5,000 professionals worldwide and a presence in over 162 locations through its member firms and collaborating firms.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OKEx To Launch Options Trading9.12.2019 09:30:00 CET | Press release
OKEx, the world’s largest spot and futures digital asset exchange by trading volume, today announced the launch of options trading. Developed from the ground up, OKEx Options represents a complete upgrade to the platform’s trading architecture, backed by a faster, more stable and robust infrastructure. Options trading will be available on OKEx starting from December 27, 2019, and simulation will begin on December 12, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191209005034/en/ (Graphic: Business Wire) With this addition, OKEx is the first crypto exchange to offer C2C, spot, futures, perpetual swap, and options trading under the same roof. Users can select from a wide range of products to best fit their trading and hedging strategies. Options trading is a type of derivatives trading that gives the buyer the ability to purchase or sell an underlying asset after paying a premium. OKEx Options will offer both buy and wr
Sabio Group Strengthens Leadership to Support Accelerated Growth9.12.2019 09:00:00 CET | Press release
Sabio Group has strengthened its leadership team to support the company’s goal of becoming a dominant player in the Customer Experience market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191209005053/en/ Jonathan Gale appointed as Sabio Group CEO (Photo: Business Wire) To further accelerate its core strategy, Jonathan Gale has been appointed as Sabio Group CEO where he will lead the ongoing development, communication and execution of a clear and compelling strategy for Sabio for the next stage of its journey. Jonathan brings over 30 years’ experience in the SaaS technology industry, 20 of which being focused on Customer Experience and Contact Centres. This knowledge, combined with a detailed understanding of the creation of cloud products and services, will help Sabio build on its existing platform of Contact Centre, Digital and Insight offerings. Jonathan’s background includes leading NewVoiceMedia as CEO from start-up
Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis9.12.2019 08:00:00 CET | Press release
Galderma today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational therapy nemolizumab for the treatment of pruritus associated with prurigo nodularis. Prurigo nodularis is a rare, potentially debilitating, chronic skin condition with thick skin nodules covering large body areas and associated severe pruritus. It frequently leads to a severe quality of life impairment. Nemolizumab is a first-in-class investigational monoclonal antibody that blocks signaling of IL-31. Galderma recently presented, at the 28th Annual Congress of the European Academy of Dermatology and Venereology, the results of a Phase 2 study in adult patients with moderate-to-severe prurigo nodularis. Nemolizumab not only met the primary endpoint of a greater improvement in peak pruritus Numerical Rating Scale (PP NRS) from baseline compared to placebo, but also significantly improved skin lesions as measured by Investigator Global Assessment (I
Immunocore announces dosing of first patient with third ImmTAC® bispecific9.12.2019 07:06:00 CET | Press release
Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announced the start of the first-in-human clinical trial of IMC-C103C, the third bispecific developed using the company’s innovative ImmTAC® technology platform. IMC-C103C is focused on targeting tumours that express the protein MAGE-A4 (Melanoma-Associated Antigen A4) and is being developed in partnership with Genentech, a member of the Roche Group. The trial (IMC-C103C-101) is designed to study the safety and preliminary activity of IMC-C103C as a monotherapy and in combination with atezolizumab (Tecentriq®) in patients with MAGE-A4-expressing cancers. David Berman, Head of Research and Development at Immunocore, commented: “We have now brought our third TCR- engineered bispecific ImmTAC into the clinic. IMC-C103C is designed to re-direct T cells to attack MAGE-A4 expressing tumours and we’re pleased to be moving its clinical development forward in partnership with Genentech.” - Ends - About Immunocore I
SAS (Scandinavian Airlines) Improves Customer Service and Cuts Costs with Scandit’s Barcode Scanning on Smartphones9.12.2019 07:00:00 CET | Press release
Scandit, the leading enterprise technology platform for mobile computer vision and augmented reality (AR), today announced that SAS (Scandinavian Airlines System) has integrated its powerful scanning software into their new Ground Handling App for smartphones, to replace expensive built-in scanners and upgrade critical ground workflows. The mobile app (developed by Stockholm-based Objective Solutions) brings new efficiency and cost savings to workflows using mobile scanning of boarding passes, passports, meal vouchers and baggage tags. SAS has deployed the Scandit-powered app to their three Scandinavian airport hubs: Stockholm Arlanda, Oslo Gardermoen, and Copenhagen Kastrup. A detailed case study about the integration is now available. SAS carries more than 30 million passengers annually to 120 destinations on over 170 aircraft and is widely recognized as a pioneer in digital innovation for the air travel industry. The Ground Handling App is part of a global, digital infrastructure in
Verimatrix Completes Sale of its Silicon IP Business Unit to Rambus9.12.2019 06:30:00 CET | Press release
Regulatory News: Verimatrix (Euronext Paris: VMX), formerly known as Inside Secure, a global provider of security and analytics solutions that protect devices, services and applications, today announced the completion of the sale of its Silicon IP and Secure Protocols business unit to Rambus Inc. (NASDAQ: RMBS) for a total cash consideration of $65 million including an earn-out. Verimatrix received an amount of $45m at closing and could receive an additional amount of up to $20 million, subject to completion of certain revenue targets for the transferred business for the calendar year 2020. This transaction increases Verimatrix’ focus as a pure player in software-based security and business intelligence solutions, while substantially improving the company’s financial flexibility thanks to a strengthened balance-sheet. At completion of the transaction, Verimatrix’s net debt1 is estimated at $17.5 million and $(2.5) million in case the earn out is achieved in full (compared with net debt